Content about HB

March 8, 2013
Fla. bill allows biosimilar, branded substitution

A new bill (HB 365) in Florida's state legislature would allow pharmacists to substitute biosimilars for branded biotech drugs, according to published reports.

A new bill (HB 365) in Florida's state legislature would allow pharmacists to substitute biosimilars for branded biotech drugs, according to published reports. The Sarasota Herald-Tribune reported that the Health Quality Subcommittee of the Florida House of Representatives approved a bill that would allow for substitution while requiring pharmacists to notify prescribing physicians within five days and require the doctor and pharmacist to maintain a record for at least four years. A similar bill (SB 732) is pending in the Florida Senate, according to reports.

March 31, 2011
NCPA: Florida bill sacrifices indie pharmacy in war on drugs

The National Community Pharmacists Association on Thursday spoke out against a Florida bill sponsored by state Rep. Rob Schenck, R-District 44, which would restrict the dispensing of controlled substances on Schedule II and III to publicly traded pharmacy chains and pharmacies that have more than $100 million in taxable revenues, or only those independent community pharmacies that have been in business more than 10 years.

ALEXANDRIA, Va. — The National Community Pharmacists Association on Thursday spoke out against a Florida bill sponsored by state Rep. Rob Schenck, R-District 44, which would restrict the dispensing of controlled substances on Schedule II and III to publicly traded pharmacy chains and pharmacies that have more than $100 million in taxable revenues, or only those independent community pharmacies that have been in business more than 10 years.

February 4, 2011
Tennessee legislators have PSE choice between NPLEx and Rx-only

Tennessee may be the next state to adopt an electronic tracking tool to enforce pseudoephedrine sales restrictions and combat methamphetamine production in real time.

NASHVILLE — Tennessee may be the next state to adopt an electronic tracking tool to enforce pseudoephedrine sales restrictions and combat methamphetamine production in real time.